Adverum Biotechnologies, Inc. (ADVM) Social Stream



Adverum Biotechnologies, Inc. (ADVM): $14.66

0.51 (+3.60%)

POWR Rating

Component Grades

Momentum

C

Stability

D

Sentiment

Quality

C

Add ADVM to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#99 of 363

in industry

ADVERUM BIOTECHNOLOGIES INC (ADVM) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering ADVERUM BIOTECHNOLOGIES INC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-05 6 $13 $3 $6 $0.835 618.56%
2022-03-30 4 $6 $4 $5 $0.835 498.8%
2022-04-11 4 $4 $3 $3.5 $0.835 319.16%
2022-05-15 3 $4 $3 $3.5 $0.835 319.16%
2022-05-27 3 $3 $3 $3 $0.835 259.28%
2022-07-07 3 $4 $3 $3.5 $0.835 319.16%
2022-08-15 3 $4 $2.5 $3.25 $0.835 289.22%
2022-08-16 3 $6 $2.5 $4.25 $0.835 408.98%
2022-11-14 3 $6 $2 $3.666 $0.835 339.04%
2023-03-31 4 $6 $2 $3.25 $0.835 289.22%
2023-05-12 5 $6 $2 $3.25 $0.835 289.22%
2023-06-19 5 $6 $2 $3.5 $0.835 319.16%
2023-07-18 5 $6 $2 $3.75 $0.835 349.1%
2023-08-11 5 $6 $2 $3.75 $0.835 349.1%
2023-08-14 5 $6 $3 $4.25 $0.835 408.98%
2023-11-03 6 $6 $2 $3.8 $0.835 355.09%
2023-11-15 6 $6 $2 $4 $0.835 379.04%

The Trend in the Analyst Price Target


Over the past 15 months, ADVM's average price target has gone up $0.75.

Over the past 36 weeks, ADVM's average upside potential has been 264.89%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-03-31 4 6 2 3.25 0.717 353.28%
2023-05-12 5 6 2 3.25 0.810 301.23%
2023-05-15 5 6 2 3.50 0.830 321.69%
2023-07-18 5 6 2 3.75 2.210 69.68%
2023-11-03 6 6 2 4.00 0.931 329.65%

ADVM Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.33 5 0 1 0 0 6

The Trend in the Broker Recommendations


ADVM's average broker recommendation rating improved by 0.77 over the prior 32 months.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for ADVM as an investment opportunity.

  • ADVM has a higher average analyst price target than 51.31% of all US stocks.
  • ADVERUM BIOTECHNOLOGIES INC's upside potential (average analyst target price relative to current price) is greater than 1748.57% of all US stocks.
  • In the context of Healthcare stocks, ADVERUM BIOTECHNOLOGIES INC's number of analysts covering the stock is greater than 373.11% of them.
  • To contextualize these metrics, consider that out of stocks in the small market cap category, ADVERUM BIOTECHNOLOGIES INC's variance in analysts' estimates is lower than -1214.99% of them.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to ADVERUM BIOTECHNOLOGIES INC are CGEN, ONVO, and PALI.

What is the outlook for ADVM? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!